Amid President Obama's push to trim government and private-sector spending on health care, one drug maker is lobbying hard to extend the patent protection of a costly drug - an extension that could cost taxpayers and patients $1 billion.
Friday, October 23, 2009
Will Congress cover for a drug-maker's billion-dollar mistake?
Did you hear about the drug-maker that missed a filing deadline by one day, and so it could lose a billion dollars. My column explains the sausage making that has resulted: